Award
NIH Reporter #11350875
Targeting drivers of tumor heterogeneity to block the progression to neuroendocrine prostate cancer
Recipient
Weill Cornell Medicine
Award Amount
$196,745.00
Ceiling
$196,745.00
Awarded
May 19, 2026
Identifier
11350875
Research project awarded by the National Cancer Institute to study tumor heterogeneity and therapeutic resistance in prostate cancer using advanced bioinformatics and gene editing techniques.
Description
The project focuses on understanding lineage plasticity in prostate cancer, identifying biomarkers, and developing strategies to overcome therapeutic resistance. The award is part of NIH PAR-21-128. The project involves bioinformatics, gene editing, and epigenetic studies. The environment at Weill Cornell Medicine is considered ideal for this research.